| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 2.02e-08 | 14 | 44 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 3.99e-08 | 4 | 44 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 3.99e-08 | 4 | 44 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 3.99e-08 | 4 | 44 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 9.95e-08 | 5 | 44 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 9.95e-08 | 5 | 44 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 9.95e-08 | 5 | 44 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 9.95e-08 | 5 | 44 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 9.95e-08 | 5 | 44 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 9.95e-08 | 5 | 44 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 9.95e-08 | 5 | 44 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.99e-07 | 6 | 44 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 2.11e-07 | 24 | 44 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.96e-07 | 26 | 44 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 3.47e-07 | 27 | 44 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 3.47e-07 | 7 | 44 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 5.39e-07 | 30 | 44 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 5.55e-07 | 8 | 44 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 5.55e-07 | 8 | 44 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 5.55e-07 | 8 | 44 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 7.05e-07 | 32 | 44 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 8.31e-07 | 9 | 44 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 8.31e-07 | 9 | 44 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.19e-06 | 10 | 44 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.19e-06 | 10 | 44 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.57e-06 | 14 | 44 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 3.72e-06 | 48 | 44 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 6.93e-06 | 56 | 44 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 9.14e-06 | 60 | 44 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.11e-05 | 20 | 44 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.42e-05 | 3 | 44 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.51e-05 | 26 | 44 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.20e-05 | 33 | 44 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 5.64e-05 | 95 | 44 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 5.69e-05 | 34 | 44 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | alcohol binding | 7.45e-05 | 102 | 44 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 8.63e-05 | 39 | 44 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 8.97e-05 | 107 | 44 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 9.32e-05 | 40 | 44 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 1.69e-04 | 9 | 44 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.74e-04 | 127 | 44 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | steroid binding | 2.08e-04 | 133 | 44 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.39e-04 | 138 | 44 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 2.58e-04 | 11 | 44 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 3.45e-04 | 62 | 44 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 3.45e-04 | 62 | 44 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.25e-04 | 14 | 44 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 5.52e-04 | 172 | 44 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.10e-04 | 18 | 44 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | lipid binding | 1.26e-03 | 988 | 44 | 8 | GO:0008289 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.87e-03 | 239 | 44 | 4 | GO:0031406 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.08e-03 | 115 | 44 | 3 | GO:0004497 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.12e-03 | 31 | 44 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.33e-03 | 254 | 44 | 4 | GO:0043177 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.40e-03 | 33 | 44 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.60e-03 | 262 | 44 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 3.20e-03 | 134 | 44 | 3 | GO:0003697 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 5.44e-03 | 50 | 44 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 5.65e-03 | 51 | 44 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 8.93e-03 | 194 | 44 | 3 | GO:0016705 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.19e-02 | 875 | 44 | 6 | GO:0019904 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.29e-02 | 891 | 44 | 6 | GO:0008270 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 3.88e-08 | 4 | 45 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 3.88e-08 | 4 | 45 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 3.88e-08 | 4 | 45 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 3.88e-08 | 4 | 45 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 9.67e-08 | 5 | 45 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 9.67e-08 | 5 | 45 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 9.67e-08 | 5 | 45 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 9.67e-08 | 5 | 45 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 9.67e-08 | 5 | 45 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 9.67e-08 | 5 | 45 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.93e-07 | 6 | 45 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.93e-07 | 6 | 45 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 3.38e-07 | 7 | 45 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 3.38e-07 | 7 | 45 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 3.38e-07 | 7 | 45 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 8.08e-07 | 9 | 45 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.15e-06 | 10 | 45 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.15e-06 | 10 | 45 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.15e-06 | 10 | 45 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.15e-06 | 10 | 45 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.15e-06 | 10 | 45 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.58e-06 | 11 | 45 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.58e-06 | 11 | 45 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 3.29e-06 | 47 | 45 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 3.47e-06 | 14 | 45 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 3.47e-06 | 14 | 45 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 4.34e-06 | 15 | 45 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 5.33e-06 | 16 | 45 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 5.33e-06 | 16 | 45 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 7.74e-06 | 18 | 45 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 8.85e-06 | 129 | 45 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 1.26e-05 | 21 | 45 | 3 | GO:0048385 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.26e-05 | 21 | 45 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 1.26e-05 | 21 | 45 | 3 | GO:0016114 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.26e-05 | 21 | 45 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.26e-05 | 21 | 45 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 1.45e-05 | 22 | 45 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.45e-05 | 22 | 45 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 1.45e-05 | 22 | 45 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 1.45e-05 | 22 | 45 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.67e-05 | 23 | 45 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.67e-05 | 23 | 45 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 1.93e-05 | 73 | 45 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.36e-05 | 158 | 45 | 5 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 2.44e-05 | 26 | 45 | 3 | GO:0010566 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 3.06e-05 | 28 | 45 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 3.41e-05 | 29 | 45 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 3.41e-05 | 29 | 45 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 4.22e-05 | 89 | 45 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 4.60e-05 | 32 | 45 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 5.06e-05 | 33 | 45 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 5.22e-05 | 94 | 45 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 5.44e-05 | 95 | 45 | 4 | GO:0006081 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 5.54e-05 | 34 | 45 | 3 | GO:0006706 | |
| GeneOntologyBiologicalProcess | response to alcohol | 5.66e-05 | 312 | 45 | 6 | GO:0097305 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 6.05e-05 | 35 | 45 | 3 | GO:0120255 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 6.59e-05 | 36 | 45 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 6.59e-05 | 36 | 45 | 3 | GO:0008299 | |
| GeneOntologyBiologicalProcess | DNA repair | 7.01e-05 | 648 | 45 | 8 | GO:0006281 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 7.76e-05 | 38 | 45 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 8.05e-05 | 105 | 45 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 8.35e-05 | 106 | 45 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 8.35e-05 | 106 | 45 | 4 | GO:0050810 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 8.55e-05 | 207 | 45 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | PAXIP1 ESCO2 HLTF MMS22L UPF1 MCM10 TBRG1 SMCHD1 TOP3A RAD9A | 8.92e-05 | 1081 | 45 | 10 | GO:0006259 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 9.06e-05 | 40 | 45 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 1.05e-04 | 42 | 45 | 3 | GO:0071398 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.21e-04 | 358 | 45 | 6 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.21e-04 | 358 | 45 | 6 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.28e-04 | 362 | 45 | 6 | GO:0000375 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.29e-04 | 45 | 45 | 3 | GO:0008207 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 1.84e-04 | 130 | 45 | 4 | GO:0097306 | |
| GeneOntologyBiologicalProcess | DNA damage response | 1.91e-04 | 959 | 45 | 9 | GO:0006974 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 2.12e-04 | 135 | 45 | 4 | GO:0019218 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 2.48e-04 | 56 | 45 | 3 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 2.61e-04 | 57 | 45 | 3 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 2.61e-04 | 57 | 45 | 3 | GO:0042181 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 2.72e-04 | 144 | 45 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 2.75e-04 | 58 | 45 | 3 | GO:0032350 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 3.04e-04 | 60 | 45 | 3 | GO:1904037 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.22e-04 | 67 | 45 | 3 | GO:0019748 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 4.60e-04 | 69 | 45 | 3 | GO:0070542 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 5.64e-04 | 74 | 45 | 3 | GO:2000351 | |
| GeneOntologyBiologicalProcess | DNA replication | 5.71e-04 | 312 | 45 | 5 | GO:0006260 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 6.32e-04 | 180 | 45 | 4 | GO:0120254 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 6.83e-04 | 79 | 45 | 3 | GO:0072577 | |
| GeneOntologyBiologicalProcess | RNA splicing | 7.34e-04 | 502 | 45 | 6 | GO:0008380 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 7.35e-04 | 81 | 45 | 3 | GO:0071384 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 7.97e-04 | 336 | 45 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 8.74e-04 | 343 | 45 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 9.35e-04 | 88 | 45 | 3 | GO:0071277 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 9.67e-04 | 89 | 45 | 3 | GO:2000379 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 1.03e-03 | 91 | 45 | 3 | GO:0051055 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 1.10e-03 | 209 | 45 | 4 | GO:0006694 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.19e-03 | 551 | 45 | 6 | GO:0006397 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 1.20e-03 | 96 | 45 | 3 | GO:1901657 | |
| GeneOntologyBiologicalProcess | response to estrogen | 1.47e-03 | 103 | 45 | 3 | GO:0043627 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 2.00e-03 | 246 | 45 | 4 | GO:0046890 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.02e-03 | 115 | 45 | 3 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 2.69e-03 | 443 | 45 | 5 | GO:1903311 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.62e-04 | 9 | 45 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.46e-04 | 11 | 45 | 2 | GO:0031094 | |
| MousePheno | parturition failure | 1.86e-06 | 10 | 36 | 3 | MP:0012010 | |
| MousePheno | hypermyelination | 2.55e-06 | 11 | 36 | 3 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 4.41e-06 | 13 | 36 | 3 | MP:0010160 | |
| MousePheno | long gestation period | 6.99e-06 | 15 | 36 | 3 | MP:0002293 | |
| MousePheno | increased circulating progesterone level | 6.99e-06 | 15 | 36 | 3 | MP:0005186 | |
| MousePheno | long stride length | 6.99e-06 | 15 | 36 | 3 | MP:0010540 | |
| MousePheno | abnormal gestational length | 1.25e-05 | 18 | 36 | 3 | MP:0002292 | |
| MousePheno | dysmyelination | 1.74e-05 | 20 | 36 | 3 | MP:0013438 | |
| MousePheno | decreased oligodendrocyte number | 3.47e-05 | 25 | 36 | 3 | MP:0009808 | |
| MousePheno | prolonged diestrus | 6.07e-05 | 30 | 36 | 3 | MP:0009011 | |
| MousePheno | abnormal parturition | 8.12e-05 | 33 | 36 | 3 | MP:0002907 | |
| MousePheno | abnormal diestrus | 9.70e-05 | 35 | 36 | 3 | MP:0009010 | |
| MousePheno | embryonic lethality prior to tooth bud stage | PAXIP1 ESCO2 EHBP1 FGF8 AP2M1 UPF1 MCM10 SPOUT1 PRPF3 SF1 TOP3A RAD9A | 1.10e-04 | 1383 | 36 | 12 | MP:0013293 |
| MousePheno | enhanced coordination | 1.24e-04 | 38 | 36 | 3 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 1.35e-04 | 39 | 36 | 3 | MP:0009006 | |
| MousePheno | decreased vocalization | 2.21e-04 | 46 | 36 | 3 | MP:0020351 | |
| MousePheno | abnormal somite development | 2.44e-04 | 222 | 36 | 5 | MP:0001688 | |
| MousePheno | abnormal amnion morphology | 2.51e-04 | 48 | 36 | 3 | MP:0005029 | |
| MousePheno | abnormal circulating progesterone level | 2.83e-04 | 50 | 36 | 3 | MP:0005184 | |
| MousePheno | abnormal oligodendrocyte morphology | 3.00e-04 | 51 | 36 | 3 | MP:0000953 | |
| MousePheno | increased stereotypic behavior | 3.36e-04 | 53 | 36 | 3 | MP:0001409 | |
| MousePheno | abnormal progesterone level | 3.55e-04 | 54 | 36 | 3 | MP:0011384 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 6.34e-04 | 772 | 36 | 8 | MP:0014259 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | 6.73e-04 | 779 | 36 | 8 | MP:0014257 | |
| MousePheno | abnormal stride length | 1.21e-03 | 82 | 36 | 3 | MP:0012690 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.17e-06 | 10 | 41 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 1.17e-06 | 10 | 41 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.17e-06 | 10 | 41 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.17e-06 | 10 | 41 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.17e-06 | 10 | 41 | 3 | PS00063 | |
| Domain | - | 5.39e-06 | 16 | 41 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 6.54e-06 | 17 | 41 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 6.54e-06 | 17 | 41 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 6.54e-06 | 17 | 41 | 3 | IPR001395 | |
| Domain | InsP3_rcpt-bd | 1.41e-05 | 3 | 41 | 2 | IPR000493 | |
| Domain | RIH_assoc | 7.01e-05 | 6 | 41 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 7.01e-05 | 6 | 41 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 7.01e-05 | 6 | 41 | 2 | PF01365 | |
| Domain | RIH_dom | 7.01e-05 | 6 | 41 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.01e-05 | 6 | 41 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.01e-05 | 6 | 41 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 7.01e-05 | 6 | 41 | 2 | PF08709 | |
| Domain | - | 7.01e-05 | 6 | 41 | 2 | 1.25.10.30 | |
| Domain | MIR | 2.09e-04 | 10 | 41 | 2 | PS50919 | |
| Domain | MIR | 2.09e-04 | 10 | 41 | 2 | PF02815 | |
| Domain | MIR | 2.09e-04 | 10 | 41 | 2 | SM00472 | |
| Domain | MIR_motif | 2.09e-04 | 10 | 41 | 2 | IPR016093 | |
| Domain | ARM-type_fold | 6.36e-03 | 339 | 41 | 4 | IPR016024 | |
| Domain | ZnF_C2HC | 6.49e-03 | 55 | 41 | 2 | SM00343 | |
| Domain | Znf_CCHC | 6.49e-03 | 55 | 41 | 2 | IPR001878 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 4.90e-07 | 28 | 33 | 4 | MM15188 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 9.72e-07 | 9 | 33 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 9.72e-07 | 9 | 33 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.90e-06 | 11 | 33 | 3 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.29e-06 | 13 | 33 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.29e-06 | 13 | 33 | 3 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 4.18e-06 | 14 | 33 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.18e-06 | 14 | 33 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 4.18e-06 | 14 | 33 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.18e-06 | 14 | 33 | 3 | MM14748 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 4.89e-06 | 49 | 33 | 4 | MM15186 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 5.22e-06 | 15 | 33 | 3 | MM14870 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.00e-05 | 23 | 33 | 3 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.00e-05 | 23 | 33 | 3 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.00e-05 | 23 | 33 | 3 | MM14741 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.05e-05 | 70 | 33 | 4 | M16794 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 5.29e-05 | 5 | 33 | 2 | M49000 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.08e-05 | 33 | 33 | 3 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.08e-05 | 33 | 33 | 3 | MM14737 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 7.92e-05 | 6 | 33 | 2 | M47960 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.45e-04 | 44 | 33 | 3 | M499 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.55e-04 | 45 | 33 | 3 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.55e-04 | 45 | 33 | 3 | MM14751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.36e-04 | 10 | 33 | 2 | M47661 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 2.82e-04 | 55 | 33 | 3 | M47952 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.82e-04 | 55 | 33 | 3 | M14933 | |
| Pathway | WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS | 2.88e-04 | 11 | 33 | 2 | M39749 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.88e-04 | 11 | 33 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.88e-04 | 11 | 33 | 2 | M27466 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.83e-04 | 61 | 33 | 3 | MM14861 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 4.08e-04 | 13 | 33 | 2 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 4.08e-04 | 13 | 33 | 2 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 6.25e-04 | 16 | 33 | 2 | M26945 | |
| Pathway | WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT | 7.94e-04 | 18 | 33 | 2 | M39808 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 8.81e-04 | 81 | 33 | 3 | M39490 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 8.86e-04 | 19 | 33 | 2 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.86e-04 | 19 | 33 | 2 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 8.86e-04 | 19 | 33 | 2 | M47733 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 9.83e-04 | 191 | 33 | 4 | MM15586 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 9.83e-04 | 20 | 33 | 2 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.09e-03 | 21 | 33 | 2 | M47689 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.19e-03 | 22 | 33 | 2 | M27445 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.19e-03 | 22 | 33 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.19e-03 | 22 | 33 | 2 | M47675 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.27e-03 | 92 | 33 | 3 | MM14881 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.30e-03 | 23 | 33 | 2 | M47676 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.30e-03 | 532 | 33 | 6 | M27870 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.40e-03 | 95 | 33 | 3 | M29842 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.54e-03 | 25 | 33 | 2 | MM14511 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.80e-03 | 27 | 33 | 2 | MM15053 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.80e-03 | 27 | 33 | 2 | M12123 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.91e-03 | 106 | 33 | 3 | M27077 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.93e-03 | 28 | 33 | 2 | M924 | |
| Pathway | REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS | 1.93e-03 | 28 | 33 | 2 | M11362 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.52e-03 | 32 | 33 | 2 | MM14983 | |
| Pathway | REACTOME_DRUG_ADME | 2.66e-03 | 119 | 33 | 3 | MM15692 | |
| Pathway | PID_ATM_PATHWAY | 2.84e-03 | 34 | 33 | 2 | M84 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | 2.87e-03 | 1081 | 33 | 8 | M27548 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 3.13e-03 | 126 | 33 | 3 | MM15553 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 3.19e-03 | 36 | 33 | 2 | MM15281 | |
| Pathway | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | 3.19e-03 | 36 | 33 | 2 | MM14687 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 3.19e-03 | 36 | 33 | 2 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.19e-03 | 36 | 33 | 2 | M39831 | |
| Pathway | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | 3.36e-03 | 37 | 33 | 2 | M11153 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 3.36e-03 | 37 | 33 | 2 | M27568 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 3.72e-03 | 134 | 33 | 3 | M29840 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 4.12e-03 | 41 | 33 | 2 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 4.32e-03 | 42 | 33 | 2 | M791 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 4.46e-03 | 143 | 33 | 3 | M27107 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 4.46e-03 | 143 | 33 | 3 | MM15383 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 4.52e-03 | 43 | 33 | 2 | M27588 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 4.52e-03 | 43 | 33 | 2 | M27443 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 4.73e-03 | 44 | 33 | 2 | M39845 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 4.73e-03 | 146 | 33 | 3 | MM15292 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 4.73e-03 | 146 | 33 | 3 | M27288 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 4.94e-03 | 45 | 33 | 2 | M39355 | |
| Pathway | SIG_CHEMOTAXIS | 4.94e-03 | 45 | 33 | 2 | M5193 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 5.16e-03 | 46 | 33 | 2 | M8626 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 1.20e-09 | 12 | 45 | 4 | 28893949 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 20124700 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 10702227 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 17034817 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 8.09e-09 | 4 | 45 | 3 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 8.09e-09 | 4 | 45 | 3 | 16508162 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 19487289 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 17629694 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 8.09e-09 | 4 | 45 | 3 | 14967952 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 8.09e-09 | 4 | 45 | 3 | 15193432 | |
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 8.09e-09 | 4 | 45 | 3 | 29764944 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 10526179 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 17888864 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 8.09e-09 | 4 | 45 | 3 | 31479646 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 17442338 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 28329705 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 16018803 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 17272929 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 8.09e-09 | 4 | 45 | 3 | 18667791 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 15222881 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 28259989 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 16191478 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 21521174 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 8274401 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 16511129 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 8.09e-09 | 4 | 45 | 3 | 34590152 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 15577209 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 7789999 | ||
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 7737980 | ||
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 10672042 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.02e-08 | 5 | 45 | 3 | 21851338 | |
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 38788959 | ||
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 17872381 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.02e-08 | 5 | 45 | 3 | 16984997 | |
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.02e-08 | 5 | 45 | 3 | 17064890 | |
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 18003893 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL10A MED14 AP2M1 UPF1 MCM10 DNAJC10 SPOUT1 PRPF3 SMCHD1 CHMP2B | 3.70e-08 | 759 | 45 | 10 | 35915203 |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 4.04e-08 | 6 | 45 | 3 | 29107092 | |
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 4.04e-08 | 6 | 45 | 3 | 26748576 | |
| Pubmed | 4.04e-08 | 6 | 45 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 4.04e-08 | 6 | 45 | 3 | 17255200 | |
| Pubmed | 4.04e-08 | 6 | 45 | 3 | 19273550 | ||
| Pubmed | 4.04e-08 | 6 | 45 | 3 | 15860270 | ||
| Pubmed | 4.04e-08 | 6 | 45 | 3 | 15471942 | ||
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 4.89e-08 | 28 | 45 | 4 | 29879378 | |
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 7.06e-08 | 7 | 45 | 3 | 34843575 | |
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 22529366 | ||
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 33127481 | ||
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 12562828 | ||
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 26160177 | ||
| Pubmed | 7.06e-08 | 7 | 45 | 3 | 16337335 | ||
| Pubmed | 1.13e-07 | 8 | 45 | 3 | 20837989 | ||
| Pubmed | 1.13e-07 | 8 | 45 | 3 | 33584538 | ||
| Pubmed | 1.13e-07 | 8 | 45 | 3 | 9224647 | ||
| Pubmed | 1.69e-07 | 9 | 45 | 3 | 33348080 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 2.41e-07 | 10 | 45 | 3 | 36313771 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 4.42e-07 | 12 | 45 | 3 | 21256921 | |
| Pubmed | 4.42e-07 | 12 | 45 | 3 | 25774556 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 5.74e-07 | 13 | 45 | 3 | 15117747 | |
| Pubmed | 5.74e-07 | 13 | 45 | 3 | 11682476 | ||
| Pubmed | 5.74e-07 | 13 | 45 | 3 | 17062636 | ||
| Pubmed | 5.74e-07 | 13 | 45 | 3 | 24580729 | ||
| Pubmed | 7.29e-07 | 14 | 45 | 3 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 7.29e-07 | 14 | 45 | 3 | 34400844 | |
| Pubmed | 1.36e-06 | 17 | 45 | 3 | 32243503 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.48e-06 | 440 | 45 | 7 | 34244565 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 7650035 | ||
| Pubmed | Local androgen inactivation in abdominal visceral adipose tissue. | 1.64e-06 | 2 | 45 | 2 | 14671194 | |
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 1.64e-06 | 2 | 45 | 2 | 19120126 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 18708078 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 15201137 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 33675863 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 1.64e-06 | 2 | 45 | 2 | 23582047 | |
| Pubmed | Isolation and characterization of cloned cDNAs encoding human liver chlordecone reductase. | 1.64e-06 | 2 | 45 | 2 | 2187532 | |
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 1.93e-06 | 19 | 45 | 3 | 17599069 | |
| Pubmed | 2.27e-06 | 20 | 45 | 3 | 23636947 | ||
| Pubmed | 2.27e-06 | 20 | 45 | 3 | 24135228 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.60e-06 | 934 | 45 | 9 | 33916271 | |
| Pubmed | 3.52e-06 | 23 | 45 | 3 | 23685333 | ||
| Pubmed | 4.56e-06 | 25 | 45 | 3 | 26098214 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 19320734 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 31979185 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 10874040 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 9808793 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 4.91e-06 | 3 | 45 | 2 | 24904548 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 20395455 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 4.91e-06 | 3 | 45 | 2 | 31780644 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 17327232 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 17437169 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23223241 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 7626489 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21232532 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 16014380 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 13678667 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 18194433 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 17890015 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 18547250 | ||
| Interaction | AKR1C4 interactions | 5.40e-07 | 8 | 44 | 3 | int:AKR1C4 | |
| Interaction | ZBTB8A interactions | 8.89e-07 | 81 | 44 | 5 | int:ZBTB8A | |
| Interaction | AKR1C1 interactions | 1.08e-05 | 20 | 44 | 3 | int:AKR1C1 | |
| Interaction | HECTD1 interactions | RPL10A MED14 AP2M1 UPF1 MCM10 DNAJC10 SPOUT1 PRPF3 SMCHD1 CHMP2B | 4.00e-05 | 984 | 44 | 10 | int:HECTD1 |
| Interaction | ZBTB8B interactions | 5.54e-05 | 34 | 44 | 3 | int:ZBTB8B | |
| Interaction | SIRT6 interactions | 5.59e-05 | 628 | 44 | 8 | int:SIRT6 | |
| Interaction | BRCA1 interactions | RPL10A HLTF MMS22L UPF1 MCM10 DNAJC10 PRPF3 SMCHD1 TOP3A RAD9A ITPR1 | 5.70e-05 | 1249 | 44 | 11 | int:BRCA1 |
| Interaction | AKR1C3 interactions | 7.16e-05 | 37 | 44 | 3 | int:AKR1C3 | |
| Interaction | HERC2 interactions | 9.96e-05 | 503 | 44 | 7 | int:HERC2 | |
| Interaction | PAK2 interactions | 1.04e-04 | 216 | 44 | 5 | int:PAK2 | |
| Interaction | H3C1 interactions | 1.18e-04 | 901 | 44 | 9 | int:H3C1 | |
| Cytoband | 10p15-p14 | 1.41e-05 | 6 | 45 | 2 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 9.74e-05 | 90 | 45 | 3 | chr10p15 | |
| GeneFamily | Aldo-keto reductases | 2.26e-06 | 15 | 32 | 3 | 399 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 9.09e-06 | 3 | 32 | 2 | 297 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 7.85e-08 | 24 | 45 | 4 | MM766 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 4.80e-07 | 37 | 45 | 4 | MM630 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 1.16e-06 | 200 | 45 | 6 | M7495 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 1.20e-06 | 201 | 45 | 6 | MM500 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 3.16e-06 | 17 | 45 | 3 | MM826 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 3.45e-06 | 60 | 45 | 4 | MM847 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 5.83e-06 | 150 | 45 | 5 | MM936 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | 1.05e-05 | 293 | 45 | 6 | MM895 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.06e-05 | 25 | 45 | 3 | MM480 | |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 1.39e-05 | 85 | 45 | 4 | MM802 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.83e-05 | 190 | 45 | 5 | MM1311 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.86e-05 | 30 | 45 | 3 | MM853 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 2.31e-05 | 337 | 45 | 6 | MM16606 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP | 2.35e-05 | 200 | 45 | 5 | M9895 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 2.40e-05 | 201 | 45 | 5 | MM502 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | 2.74e-05 | 520 | 45 | 7 | MM1008 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 3.24e-05 | 36 | 45 | 3 | MM3660 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 4.12e-05 | 225 | 45 | 5 | MM496 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 6.38e-05 | 45 | 45 | 3 | MM1173 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.06e-04 | 143 | 45 | 4 | MM989 | |
| Coexpression | NFE2L2.V2 | 1.43e-04 | 469 | 45 | 6 | M2870 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 2.01e-04 | 66 | 45 | 3 | MM631 | |
| Coexpression | FISCHER_DREAM_TARGETS | 2.17e-04 | 969 | 45 | 8 | M149 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 2.29e-04 | 69 | 45 | 3 | MM621 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 2.81e-04 | 74 | 45 | 3 | MM769 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 2.85e-04 | 185 | 45 | 4 | M1137 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_UP | 3.29e-04 | 192 | 45 | 4 | MM497 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 3.41e-04 | 79 | 45 | 3 | MM535 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN | 3.76e-04 | 199 | 45 | 4 | M6507 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN | 3.76e-04 | 199 | 45 | 4 | M9170 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 3.84e-04 | 200 | 45 | 4 | M9002 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 3.84e-04 | 200 | 45 | 4 | M9215 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 4.14e-04 | 369 | 45 | 5 | MM16610 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 4.84e-04 | 19 | 45 | 2 | M1847 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 4.84e-04 | 89 | 45 | 3 | MM690 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 5.17e-04 | 1394 | 45 | 9 | M9585 | |
| Coexpression | WANG_RECURRENT_LIVER_CANCER_UP | 5.37e-04 | 20 | 45 | 2 | M10922 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | 5.40e-04 | 219 | 45 | 4 | MM1237 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 169 | 45 | 4 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.72e-05 | 172 | 45 | 4 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 177 | 45 | 4 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 183 | 45 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 183 | 45 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue | 3.77e-05 | 187 | 45 | 4 | 265c690c2921fd201361a0ec8bc4d2a996fbcaf4 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.09e-05 | 191 | 45 | 4 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.26e-05 | 193 | 45 | 4 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.44e-05 | 195 | 45 | 4 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 4.44e-05 | 195 | 45 | 4 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-05 | 195 | 45 | 4 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-MAIT|Liver / Manually curated celltypes from each tissue | 4.44e-05 | 195 | 45 | 4 | 6da0db2a36a34952daab87d74367b491582dedea | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like|Liver / Manually curated celltypes from each tissue | 4.44e-05 | 195 | 45 | 4 | 37853fe760eac27ecb2fe42ebff42deca0153400 | |
| ToppCell | PSB-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.53e-05 | 196 | 45 | 4 | 7b5c2a4cdea9a944f83bfc2c493d3076c3daaeaa | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 4.62e-05 | 197 | 45 | 4 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | VE-CD8-CD8_2|VE / Condition, Cell_class and T cell subcluster | 4.80e-05 | 199 | 45 | 4 | 014fff8a0ebfda094a6ad76ddc0131e12a313394 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.88e-05 | 70 | 45 | 3 | 37e34ef782b253c43628d5bb2fe5e0294573d0ef | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 4.89e-05 | 200 | 45 | 4 | c00cc0b91baa37828895d9d6b8acbc6aa503215a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 4.89e-05 | 200 | 45 | 4 | 9e1b62a703fb7d413ce580448a1df5127c28e8a7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.89e-05 | 200 | 45 | 4 | 6b34f2b85d4f83c1270ee151f602cba6f42042ba | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.89e-05 | 200 | 45 | 4 | b2c5618aa1ac19423996336795dadb39ea57cda7 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 4.89e-05 | 200 | 45 | 4 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | Mild/Remission-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.96e-04 | 142 | 45 | 3 | fc5fc2d2b4b976358b8ce762c1f440b20db84103 | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.47e-04 | 148 | 45 | 3 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.74e-04 | 151 | 45 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-04 | 151 | 45 | 3 | b85a763459a0f019d1f9975d09b9f2247d62c9d3 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 153 | 45 | 3 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 153 | 45 | 3 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 153 | 45 | 3 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 153 | 45 | 3 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-04 | 156 | 45 | 3 | 955547dfeb1b1ad4957b4338701055726b22619f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-04 | 156 | 45 | 3 | b28bbdb515317368f1231b0b15d7442352f3b400 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-04 | 156 | 45 | 3 | 1928c86deb3bcd01db4ae76919a351066aadb39a | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-04 | 159 | 45 | 3 | 7065062fce248e0458932a22dfcc25a5b5a70cbd | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 160 | 45 | 3 | 1cb6f42b68c9e41e8edae0de8f0d8371c4620b04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 160 | 45 | 3 | ebefde92db400cbe68d9ce31545a0308e0afbde1 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.82e-04 | 162 | 45 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-04 | 167 | 45 | 3 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-04 | 169 | 45 | 3 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.69e-04 | 170 | 45 | 3 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 171 | 45 | 3 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-04 | 172 | 45 | 3 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Basal|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.04e-04 | 173 | 45 | 3 | 3d3afc9ab234eaabf5b9bff455406231cd54ded6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 7.04e-04 | 173 | 45 | 3 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-04 | 173 | 45 | 3 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-04 | 174 | 45 | 3 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-04 | 174 | 45 | 3 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-04 | 175 | 45 | 3 | 3bca1aac2a2a1f46753b5f9462888f144ed8327b | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.40e-04 | 176 | 45 | 3 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.40e-04 | 176 | 45 | 3 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.40e-04 | 176 | 45 | 3 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.40e-04 | 176 | 45 | 3 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 7.52e-04 | 177 | 45 | 3 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 7.52e-04 | 177 | 45 | 3 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-04 | 177 | 45 | 3 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.52e-04 | 177 | 45 | 3 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-04 | 177 | 45 | 3 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-04 | 179 | 45 | 3 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-04 | 179 | 45 | 3 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-04 | 179 | 45 | 3 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-04 | 179 | 45 | 3 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-04 | 180 | 45 | 3 | a0faed4cf23f6d5e6e8f6b0284cea8a5bd0680a0 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | 145fae2746c5212640b7b11b04a7759ba8e5c322 | |
| ToppCell | COVID-19-kidney-Mito-rich_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 8.02e-04 | 181 | 45 | 3 | 8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 8.02e-04 | 181 | 45 | 3 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | a9f1fc5973cffdbeb7d1f5c41534422d85d596ff | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 8.15e-04 | 182 | 45 | 3 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-04 | 183 | 45 | 3 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.28e-04 | 183 | 45 | 3 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.28e-04 | 183 | 45 | 3 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.28e-04 | 183 | 45 | 3 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 183 | 45 | 3 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.28e-04 | 183 | 45 | 3 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 183 | 45 | 3 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-04 | 184 | 45 | 3 | 204d16c48f822c98dc4118ac97a4f99f7e1163c8 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 8.42e-04 | 184 | 45 | 3 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-04 | 184 | 45 | 3 | 9365cdc52a2419e3f27e1c1c9310fa707d1e506b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.55e-04 | 185 | 45 | 3 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.55e-04 | 185 | 45 | 3 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 8.55e-04 | 185 | 45 | 3 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-04 | 186 | 45 | 3 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-04 | 186 | 45 | 3 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.68e-04 | 186 | 45 | 3 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.68e-04 | 186 | 45 | 3 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.68e-04 | 186 | 45 | 3 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 187 | 45 | 3 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 187 | 45 | 3 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 187 | 45 | 3 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.95e-04 | 188 | 45 | 3 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | Calu_3-infected-SARSCoV1|infected / Cell line, Condition and Strain | 8.95e-04 | 188 | 45 | 3 | a689d59555ecf10bf88c886197d4f7bf9be6c586 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.95e-04 | 188 | 45 | 3 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.95e-04 | 188 | 45 | 3 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-04 | 188 | 45 | 3 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.95e-04 | 188 | 45 | 3 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.09e-04 | 189 | 45 | 3 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-04 | 189 | 45 | 3 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| Drug | Pregnanes | 2.69e-08 | 4 | 44 | 3 | ctd:D011278 | |
| Drug | tetralol | 2.69e-08 | 4 | 44 | 3 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 2.69e-08 | 4 | 44 | 3 | ctd:C018156 | |
| Drug | cloxazolam | 2.69e-08 | 4 | 44 | 3 | ctd:C005522 | |
| Drug | Hydroxysteroids | 6.72e-08 | 5 | 44 | 3 | ctd:D006914 | |
| Drug | cresolphthalein | 6.72e-08 | 5 | 44 | 3 | ctd:C010092 | |
| Drug | Medazepam | 1.34e-07 | 6 | 44 | 3 | ctd:D008472 | |
| Drug | 3-hydroxyhexobarbital | 1.34e-07 | 6 | 44 | 3 | CID000439898 | |
| Drug | 2-cyclohexen-1-ol | 3.75e-07 | 8 | 44 | 3 | CID000013198 | |
| Drug | Nitrazepam | 3.75e-07 | 8 | 44 | 3 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 5.61e-07 | 9 | 44 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 5.61e-07 | 9 | 44 | 3 | ctd:D004092 | |
| Drug | octyl gallate | 8.00e-07 | 10 | 44 | 3 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.10e-06 | 11 | 44 | 3 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.10e-06 | 11 | 44 | 3 | CID000013946 | |
| Drug | Phenolphthalein | 1.46e-06 | 12 | 44 | 3 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 1.90e-06 | 13 | 44 | 3 | CID000050096 | |
| Drug | flunisolide | 1.90e-06 | 13 | 44 | 3 | ctd:C007734 | |
| Drug | 1-acenaphthenol | 2.41e-06 | 14 | 44 | 3 | CID000022750 | |
| Drug | 5-alpha-Dihydroprogesterone | 2.41e-06 | 14 | 44 | 3 | ctd:D043582 | |
| Drug | Meclofenamic Acid | 2.41e-06 | 14 | 44 | 3 | ctd:D008469 | |
| Drug | androstane-3,17-dione | 2.84e-06 | 51 | 44 | 4 | CID000000443 | |
| Drug | MC_MO | 3.65e-06 | 2 | 44 | 2 | CID000026787 | |
| Drug | baccharin | 3.65e-06 | 2 | 44 | 2 | ctd:C012764 | |
| Drug | oxcarbazepine | 6.39e-06 | 19 | 44 | 3 | ctd:C036006 | |
| Drug | benzo(a)pyrene-7,8-dione | 7.50e-06 | 20 | 44 | 3 | ctd:C076588 | |
| Drug | Chrysenes | 7.50e-06 | 20 | 44 | 3 | ctd:D002911 | |
| Drug | Flunitrazepam | 8.74e-06 | 21 | 44 | 3 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 1.01e-05 | 22 | 44 | 3 | CID000000418 | |
| Drug | valganciclovir | 1.01e-05 | 22 | 44 | 3 | CID000064147 | |
| Drug | cyclopentanone | 1.09e-05 | 3 | 44 | 2 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.09e-05 | 3 | 44 | 2 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 1.09e-05 | 3 | 44 | 2 | ctd:C058818 | |
| Drug | cyclopentanol | 1.09e-05 | 3 | 44 | 2 | ctd:C016327 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.09e-05 | 3 | 44 | 2 | ctd:C530610 | |
| Drug | 5 beta-pregnane-3,20-dione | 1.13e-05 | 72 | 44 | 4 | CID000092745 | |
| Drug | Glycyrrhetinic Acid | 1.32e-05 | 24 | 44 | 3 | ctd:D006034 | |
| Drug | Pregnanolone | 1.50e-05 | 25 | 44 | 3 | ctd:D011280 | |
| Drug | 9,10-phenanthrenequinone | 1.50e-05 | 25 | 44 | 3 | ctd:C005399 | |
| Drug | glycolithocholic acid | 1.70e-05 | 26 | 44 | 3 | CID000115245 | |
| Drug | tetrahydrodeoxycorticosterone | 2.18e-05 | 4 | 44 | 2 | ctd:C009413 | |
| Drug | gliquidone | 2.18e-05 | 4 | 44 | 2 | ctd:C010969 | |
| Drug | DBD-H | 2.18e-05 | 4 | 44 | 2 | CID000131382 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 2.91e-05 | 31 | 44 | 3 | ctd:C017228 | |
| Drug | AC1MO44G | 2.99e-05 | 92 | 44 | 4 | CID003363161 | |
| Drug | Dasatinib | 3.37e-05 | 478 | 44 | 7 | ctd:D000069439 | |
| Drug | NSC86000 | 3.64e-05 | 5 | 44 | 2 | CID000257630 | |
| Drug | farnesal | 3.64e-05 | 5 | 44 | 2 | ctd:C084519 | |
| Drug | Benzbromarone | 3.67e-05 | 326 | 44 | 6 | ctd:D001553 | |
| Drug | terephthalate | 4.60e-05 | 36 | 44 | 3 | CID000007489 | |
| Drug | quercitrin | 4.60e-05 | 36 | 44 | 3 | CID005280459 | |
| Drug | 4-chloro-m-cresol | 5.00e-05 | 37 | 44 | 3 | CID000001732 | |
| Drug | acacetin | 5.42e-05 | 38 | 44 | 3 | CID005280442 | |
| Drug | AC1L93E5 | 5.45e-05 | 6 | 44 | 2 | CID000412383 | |
| Drug | acenaphthene-1-ol | 5.45e-05 | 6 | 44 | 2 | ctd:C023723 | |
| Drug | Estazolam | 5.45e-05 | 6 | 44 | 2 | ctd:D004949 | |
| Drug | Glipizide | 5.45e-05 | 6 | 44 | 2 | ctd:D005913 | |
| Drug | 20 alpha-dihydroprogesterone | 6.33e-05 | 40 | 44 | 3 | CID000008956 | |
| Drug | o-quinone | 6.82e-05 | 41 | 44 | 3 | CID000011421 | |
| Drug | 4-hydroxyequilenin-o-quinone | 7.62e-05 | 7 | 44 | 2 | ctd:C117714 | |
| Drug | zomepirac | 7.62e-05 | 7 | 44 | 2 | ctd:C020549 | |
| Drug | germacrane D | 7.62e-05 | 7 | 44 | 2 | CID000543807 | |
| Drug | Flufenamic Acid | 9.03e-05 | 45 | 44 | 3 | ctd:D005439 | |
| Drug | naphthalene-1,2-dihydrodiol | 9.03e-05 | 45 | 44 | 3 | CID000000362 | |
| Drug | Octa | 1.10e-04 | 48 | 44 | 3 | CID000010213 | |
| Drug | MOF-5 | 1.30e-04 | 9 | 44 | 2 | CID000139613 | |
| Drug | 7-azaindole | 1.47e-04 | 53 | 44 | 3 | CID000009222 | |
| Drug | 1H-inden-1-yl | 1.63e-04 | 10 | 44 | 2 | CID005374393 | |
| Drug | hafnium hydroxide | 1.63e-04 | 10 | 44 | 2 | CID000082817 | |
| Drug | Hexestrol | 1.65e-04 | 55 | 44 | 3 | ctd:D006589 | |
| Drug | NADH | 1.71e-04 | 144 | 44 | 4 | DB00157 | |
| Drug | 1,2-dihydroxynaphthalene | 1.83e-04 | 57 | 44 | 3 | CID000011318 | |
| Drug | phenolphthalein | 1.93e-04 | 58 | 44 | 3 | CID000004764 | |
| Drug | NSC36919 | 1.93e-04 | 58 | 44 | 3 | CID000235496 | |
| Drug | fenamic acid | 2.38e-04 | 12 | 44 | 2 | ctd:C001209 | |
| Drug | ellipticine derivative | 2.38e-04 | 12 | 44 | 2 | CID000434612 | |
| Drug | xestospongin C | 2.38e-04 | 12 | 44 | 2 | ctd:C511704 | |
| Drug | 4-formyl-benzoate | 2.81e-04 | 13 | 44 | 2 | CID000012088 | |
| Drug | chlordecone | 2.96e-04 | 67 | 44 | 3 | CID000000299 | |
| Drug | Dydrogesterone | 3.27e-04 | 14 | 44 | 2 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 3.27e-04 | 14 | 44 | 2 | CID000631219 | |
| Drug | coumarin-3-carboxylic acid | 3.77e-04 | 15 | 44 | 2 | CID000010752 | |
| Drug | indenylidene | 3.77e-04 | 15 | 44 | 2 | CID005460737 | |
| Drug | drospirenone | 3.77e-04 | 15 | 44 | 2 | ctd:C035144 | |
| Drug | protoberberine | 3.77e-04 | 15 | 44 | 2 | CID000114943 | |
| Drug | Diazepam | 3.97e-04 | 74 | 44 | 3 | ctd:D003975 | |
| Drug | 9-cis-retinal | 4.31e-04 | 16 | 44 | 2 | ctd:C031390 | |
| Drug | lead carbonate | 4.31e-04 | 16 | 44 | 2 | CID000011727 | |
| Drug | 3-phenoxybenzoic acid | 4.87e-04 | 17 | 44 | 2 | CID000019539 | |
| Drug | benzo(a)pyrene-1,6-quinone | 4.87e-04 | 17 | 44 | 2 | ctd:C030233 | |
| Drug | NAD | 4.99e-04 | 80 | 44 | 3 | ctd:D009243 | |
| Drug | Budesonide | 4.99e-04 | 80 | 44 | 3 | ctd:D019819 | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 7409_DN | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 3799_DN | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.21e-04 | 193 | 44 | 4 | 6697_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 5.31e-04 | 194 | 44 | 4 | 4272_DN | |
| Drug | 1,10-phenanthroline | 5.36e-04 | 82 | 44 | 3 | ctd:C025205 | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 44 | 4 | 2708_DN | |
| Drug | Androstane-3,17-diol | 5.48e-04 | 18 | 44 | 2 | ctd:D015113 | |
| Drug | 1,3-dichlorobenzene | 5.48e-04 | 18 | 44 | 2 | CID000010943 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 2.07e-06 | 2 | 43 | 2 | C1839840 | |
| Disease | Anoxia of brain | 2.07e-06 | 2 | 43 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 2.07e-06 | 2 | 43 | 2 | C1140716 | |
| Disease | 46,XY SEX REVERSAL 8 | 2.07e-06 | 2 | 43 | 2 | 614279 | |
| Disease | Anoxic Encephalopathy | 2.07e-06 | 2 | 43 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 2.07e-06 | 2 | 43 | 2 | C1527348 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 2.07e-06 | 2 | 43 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 2.07e-06 | 2 | 43 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | Neoplasms, Hormone-Dependent | 6.22e-06 | 3 | 43 | 2 | C0027661 | |
| Disease | Ambiguous Genitalia | 2.07e-05 | 5 | 43 | 2 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.07e-05 | 5 | 43 | 2 | C0033804 | |
| Disease | Hermaphroditism | 2.07e-05 | 5 | 43 | 2 | C0019269 | |
| Disease | Intersex Conditions | 2.07e-05 | 5 | 43 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.07e-05 | 5 | 43 | 2 | C2930619 | |
| Disease | cortolone glucuronide (1) measurement | 3.10e-05 | 6 | 43 | 2 | EFO_0800552 | |
| Disease | Disorders of Sex Development | 4.34e-05 | 7 | 43 | 2 | C0036875 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.36e-04 | 12 | 43 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | free androgen index | 2.06e-04 | 374 | 43 | 5 | EFO_0007005 | |
| Disease | obesity (implicated_via_orthology) | 2.71e-04 | 215 | 43 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 1.00e-03 | 32 | 43 | 2 | DOID:332 (is_implicated_in) | |
| Disease | Neoplastic Cell Transformation | 1.10e-03 | 139 | 43 | 3 | C0007621 | |
| Disease | Kidney Neoplasm | 1.56e-03 | 40 | 43 | 2 | C0022665 | |
| Disease | Endometrioma | 1.68e-03 | 161 | 43 | 3 | C0269102 | |
| Disease | Endometriosis | 1.68e-03 | 161 | 43 | 3 | C0014175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEKCKDAGLAKSIGV | 151 | P17516 | |
| MGTKGKVIKCKAAIA | 1 | P08319 | |
| MEKCKDAGLAKSIGV | 151 | P42330 | |
| AKGKVQAVGGSCKVM | 2196 | Q8IYW2 | |
| IKKMAKIGNKEACKV | 46 | Q9UQN3 | |
| KMQLKCLLKGKGQET | 266 | Q2M243 | |
| MKCLVTGGNVKVLGK | 1 | Q99638 | |
| IVKADGKYVKKCQDM | 1316 | Q14571 | |
| MKAIVECAGGKVLSK | 991 | Q6ZW49 | |
| VKAEGKFIKKCQDMV | 1326 | Q14643 | |
| CILAKVVKKAMKSNG | 486 | Q6ZRQ5 | |
| TGKNMCAKVAGLVLK | 491 | Q7Z3E5 | |
| DIKEKSNVGCMEFKK | 156 | O14626 | |
| MGEALDLGTCKAKKK | 381 | Q7L590 | |
| SGVQVICMKGKAKYK | 331 | Q96CW1 | |
| NDEKKMLKCVVVGDG | 16 | Q9H4E5 | |
| KKTKRAGEMCAFNKV | 626 | O60244 | |
| CKKPIAGQVVTAMGK | 361 | P49023 | |
| QLGPVVMCKKAAKAG | 676 | Q92900 | |
| ICMNKKGKLIAKSNG | 126 | P55075 | |
| IGSKKKFDKCMVCGG | 666 | O75173 | |
| RVGKMDLKDTGAKKC | 301 | Q92608 | |
| ISVKMGNKAKIAKCP | 31 | A2RUB6 | |
| QNKGKMAKKEEKCVL | 1216 | Q8NDI1 | |
| IVTEKMQGKPVCSKK | 121 | Q56NI9 | |
| MKLKKQVTVCGAAIF | 1 | P49641 | |
| TKKKMLKKGACAVEG | 451 | Q14527 | |
| MIKGKVKAGKVDCQA | 716 | Q8IXB1 | |
| NIMGKVAKCIGFAIK | 231 | P46059 | |
| FVNCGMKKEVKIDKN | 206 | Q5T280 | |
| VTAALNCVGKGMDKK | 31 | O43395 | |
| NCVGKGMDKKKAADH | 36 | O43395 | |
| KKCNLKGAFVKMSGC | 1031 | Q5THK1 | |
| EMNGKLLKGCKVFVG | 156 | P0CB38 | |
| LKCEMKGGKTVQMGQ | 1151 | A6NHR9 | |
| KKCVVVGNGGVLKNK | 116 | Q9Y274 | |
| MEKCKDAGLAKSIGV | 151 | P52895 | |
| ANGVKMKKVTKPCSD | 991 | Q96JN2 | |
| GMKCTRCGGDDKVKK | 101 | O95471 | |
| VKGKGQKTKMDCTPE | 31 | A0A0A0MS06 | |
| KFQMKKVLCLAVAVG | 156 | P62906 | |
| CNKDMVLKTKKNGGF | 661 | Q13472 | |
| CNAKIMIRGKGSVKE | 171 | Q15637 | |
| TCKKKKMAGGARKLV | 156 | Q3YBR2 | |
| MGCIKSKENKSPAIK | 1 | P07947 | |
| NGKMVAECKMKGVVC | 111 | P02689 |